Comprehensive profiling of tumor samples taken from patients with osteosarcoma shows that multiple factors contribute to the traditionally poor responses observed from treatment with immune checkpoint inhibitors, according to new research.
from Latest Science News -- ScienceDaily https://ift.tt/2HR4PIu
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment